[{"address1": "3940 Trust Way", "city": "Hayward", "state": "CA", "zip": "94545", "country": "United States", "phone": "510 780 0819", "website": "https://benitec.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jerel A. Banks M.D., Ph.D.", "age": 47, "title": "Executive Chairman & CEO", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 848068, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Graham", "title": "Head of Discovery & Founding Scientist", "fiscalYear": 2023, "totalPay": 127411, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claudia  Kloth Ph.D.", "title": "Senior Vice President of Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.5, "open": 7.35, "dayLow": 7.34, "dayHigh": 7.5525, "regularMarketPreviousClose": 7.5, "regularMarketOpen": 7.35, "regularMarketDayLow": 7.34, "regularMarketDayHigh": 7.5525, "beta": 0.732, "forwardPE": -8.244445, "volume": 23184, "regularMarketVolume": 23184, "averageVolume": 89903, "averageVolume10days": 44000, "averageDailyVolume10Day": 44000, "bid": 5.4, "ask": 9.47, "bidSize": 200, "askSize": 200, "marketCap": 69506704, "fiftyTwoWeekLow": 1.86, "fiftyTwoWeekHigh": 10.7, "priceToSalesTrailing12Months": 9929.529, "fiftyDayAverage": 7.3932, "twoHundredDayAverage": 4.43033, "currency": "USD", "enterpriseValue": 55717740, "floatShares": 6008399, "sharesOutstanding": 9367480, "sharesShort": 56144, "sharesShortPriorMonth": 12221, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.006, "heldPercentInsiders": 0.09283, "heldPercentInstitutions": 0.65704, "shortRatio": 0.28, "shortPercentOfFloat": 0.0064999997, "impliedSharesOutstanding": 9367480, "bookValue": 4.221, "priceToBook": 1.7578772, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -21692000, "trailingEps": -235.52, "forwardEps": -0.9, "lastSplitFactor": "1:17", "lastSplitDate": 1690329600, "enterpriseToRevenue": 7959.677, "enterpriseToEbitda": -2.602, "52WeekChange": 0.8262367, "SandP52WeekChange": 0.23232913, "lastDividendValue": 0.765, "lastDividendDate": 1527811200, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BNTC", "underlyingSymbol": "BNTC", "shortName": "Benitec Biopharma Inc.", "longName": "Benitec Biopharma Inc.", "firstTradeDateEpochUtc": 1403616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "b3cc27a2-16b5-3a55-8f58-57577c96b7a7", "messageBoardId": "finmb_4492928", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.42, "targetHighPrice": 16.0, "targetLowPrice": 16.0, "targetMeanPrice": 16.0, "targetMedianPrice": 16.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 14143000, "totalCashPerShare": 1.51, "ebitda": -21410000, "totalDebt": 354000, "quickRatio": 4.13, "currentRatio": 4.18, "totalRevenue": 7000, "debtToEquity": 3.078, "revenuePerShare": 0.003, "returnOnAssets": -1.15703, "returnOnEquity": -2.6758802, "freeCashflow": -11906500, "operatingCashflow": -20205000, "grossMargins": 16.42857, "operatingMargins": -3070.2856, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-10"}]